Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- MGB Biopharma Limited
- Target Recruit Count
- 34
- Registration Number
- NCT03824795
- Locations
- 🇺🇸
Florida International Medical Research, Miami, Florida, United States
🇺🇸Omega Research Maitland LLC, Orlando, Florida, United States
🇺🇸Snake River Research PLLC, Idaho Falls, Idaho, United States
Safety, Blood Levels and Effects of MGB-BP-3
- First Posted Date
- 2015-08-10
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- MGB Biopharma Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02518607
News
No news found